Tower Research Capital LLC (Trc) Pliant Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,645 shares of PLRX stock, worth $2,599. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,645
Previous 1,729
4.86%
Holding current value
$2,599
Previous $19,000
10.53%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding PLRX
# of Institutions
175Shares Held
64.8MCall Options Held
228KPut Options Held
772K-
Deep Track Capital, LP Greenwich, CT5.97MShares$9.44 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$7.86 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.63MShares$7.32 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$5.1 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.2MShares$5.05 Million1.61% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $76.9M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...